Inherited DNA changes can cause hormone imbalance in women with polycystic ovary syndrome

Journal: Nature Communications

Title: Gene Regulatory Activity Associated with Polycystic Ovary Syndrome Reveals DENND1A-Dependant Testosterone Production

Authors: Andrea Dunaif, MD, Chief of the Division of Endocrinology, Diabetes and Bone Disease for the Mount Sinai Health System and the Lillian and Henry M. Stratton Professor of Molecular Medicine at the Icahn School of Medicine at Mount Sinai

Bottom line: Increased testosterone levels are a consistent hormonal abnormality in women with polycystic ovary syndrome (PCOS). This study identified specific DNA variants in the gene DENND1A, which increase testosterone production in PCOS. Using human PCOS cell models, researchers demonstrated that activating these DNA switches turns on DENND1A and drives testosterone production. This provides the first direct evidence that inherited DNA changes can cause the hormone imbalance at the core of PCOS.

Why this study is unique: This is the first time that specific inherited DNA variants for PCOS have been shown to alter hormone production in a human PCOS cell model. While earlier studies mapped broad "regions of interest" in the genome, none had identified the precise functional switches that change hormone biology.

Why the study is important: PCOS is one of the most common conditions in reproductive-age women, affecting 10 to 15 percent of this population globally. It is a complex genetic disorder that reflects the interaction of multiple genes with the environment. PCOS is the leading cause of infertility related to disrupted ovulation and is now recognized as a major cardiometabolic disorder across the lifespan, strongly linked to type 2 diabetes and obesity. Elevated testosterone levels are its most consistent hormonal feature. Understanding how inherited DNA changes lead to increased testosterone levels could open the door to new therapies for PCOS.

How the research was conducted: Nearly 10 years ago, researchers selected the 14 genomic regions that had been associated with PCOS at that time. Using a high-throughput reporter assay, they scanned thousands of DNA sequences in those regions for regulatory activity, identifying the "regulatory switches" that control the expression of genes in hormone-producing cells. They then used genome-wide association studies (GWAS) data to determine which of these regulatory elements were associated with PCOS. This two-step design enabled researchers to focus solely on PCOS-associated regulatory regions, thereby significantly reducing the number of women with PCOS who needed to be studied.

Finally, researchers applied clustered interspaced short palindromic repeats (CRISPR)-based epigenome editing-a precise method that can turn DNA switches on or off without altering the underlying code-to activate regulatory regions in human cell models: one that produces testosterone (in adrenal steroid-producing cells) and another that produces estradiol (in ovarian granulosa cells). Researchers identified DENND1A regulatory regions that increased DENND1A expression and testosterone production in a PCOS testosterone-producing cell model, proving a direct mechanistic link between genetic variants and the hormonal features of PCOS.

Results: Researchers identified more than 1,000 regulatory DNA elements across 14 PCOS loci in hormone-producing cell models. Several regions, including FSHB, GATA4, and DENND1A, contained regulatory variants associated with PCOS. In the PCOS testosterone-producing cell model, activating the DENND1A regulatory DNA increased its expression and testosterone production.

What this study means for doctors: For clinicians, this study identifies the genetic variants in DENND1A that underlie the fundamental hormonal abnormality of PCOS, elevated testosterone levels. Previous studies had shown that a gene region containing DENND1A was associated with PCOS, but there had been no direct evidence that specific variants in the regulatory region of this gene increased testosterone production in a human PCOS cell model. This type of mechanistic insight could eventually lead to treatments aimed at lowering testosterone production at its genetic source.

What this study means for patients: For patients, this study shows that PCOS is driven in part by inherited DNA variants that directly increase testosterone production. Understanding these mechanisms opens the possibility of therapies that could target the genes or regulatory switches responsible for increased testosterone production in PCOS. High levels of testosterone, a male hormone, cause many symptoms of PCOS, such as increased male-pattern hair growth and disruption of ovulation, leading to irregular menstrual cycles and infertility.

What the next steps are for this work: This is a proof-of-concept study. DENND1A is only one of the 14 regions we studied, and there are now about 30 PCOS loci known. The next step is to apply this two-step approach to the remaining regions, including larger and more diverse populations, to build a more comprehensive picture of the disrupted pathways in PCOS.

Quotes: "For the first time, we have shown how specific inherited DNA variants in PCOS change gene activity and increase testosterone production. That moves us from statistical association to biological mechanism. Our innovative approach of first identifying regulatory regions in PCOS susceptibility genes, then determining which of these regions were associated with PCOS, allowed us to focus functional testing on regions with a high likelihood of containing disease-causing variants. Identifying the precise mechanisms by which DNA variation causes complex disorders such as PCOS is one of the major challenges in human genetics. The framework we developed could transform how we study complex disorders beyond PCOS," Dr. Dunaif said.

Source:
Journal reference:

Sankaranarayanan, L., et al. (2025). Gene regulatory activity associated with polycystic ovary syndrome revealed DENND1A-dependent testosterone production. Nature Communications. doi.org/10.1038/s41467-025-62884-7

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers trace metabolic superpowers of hibernators to shared DNA